Home › Trial NCT04599712
Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung Cancer
- Trial IDNCT04599712
- StatusUnknown
- PhaseN/A
- Study typeExpanded_Access
- SponsorJanssen Research & Development, LLC
- Enrollment—
- Start date—
- ConditionsMetastatic Non-Small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.